Gliosarcoma
Showing 1 - 25 of 94
Glioblastoma Through Preservation of Biologically Active Brain
Not yet recruiting
- Glioblastoma
- +2 more
- Specimen Collection
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 24, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)
Recruiting
- Glioblastoma Multiforme
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 30, 2023
Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)
Recruiting
- Glioblastoma
- +2 more
- TMZ
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)
Not yet recruiting
- Recurrent High Grade Glioma
- +4 more
- PCI 24781
- Temozolomide
- (no location specified)
Jan 24, 2023
Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)
Recruiting
- Glioblastoma
- Gliosarcoma
- Nedisertib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2022
Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular
Completed
- Gliosarcoma
- Recurrent Glioblastoma
- Laboratory Biomarker Analysis
- +2 more
-
Chicago, IllinoisNorthwestern University
Aug 5, 2022
Gliosarcoma, MGMT-Unmethylated Glioblastoma Trial in United States (biological, device, other, radiation, drug)
Suspended
- Gliosarcoma
- MGMT-Unmethylated Glioblastoma
- Ipilimumab
- +6 more
-
Birmingham, Alabama
- +285 more
Aug 24, 2022
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)
Active, not recruiting
- Anaplastic Astrocytoma
- +6 more
- Laboratory Biomarker Analysis
- +4 more
-
Los Angeles, California
- +11 more
Jul 1, 2022
Gliosarcoma, CNS Sarcoma Trial run by the NCI (Sunitinib, wGT3x-BT)
Terminated
- Gliosarcoma
- Central Nervous System Sarcoma
- Sunitinib
- wGT3x-BT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 24, 2022
Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))
Completed
- Malignant Glioma
- +2 more
- Bevacizumab
- +3 more
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022
Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic
Recruiting
- Gliosarcoma
- +2 more
- Selinexor
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Rochester (radiation, other, biological, drug, procedure)
Recruiting
- Glioblastoma
- +2 more
- External Beam Radiation Therapy
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 4, 2022
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Glioblastoma, Gliosarcoma Trial in Miami, Atlanta, Baltimore (radiation, procedure, drug)
Active, not recruiting
- Glioblastoma
- Gliosarcoma
- Dose-Escalated Radiation Therapy
- +2 more
-
Miami, Florida
- +2 more
Feb 16, 2022
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- bevacizumab
- +5 more
-
Los Angeles, California
- +2 more
Feb 10, 2022
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Rochester (other, biological, drug)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Nov 3, 2021
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States
Completed
- Anaplastic Astrocytoma
- +3 more
- 3-Dimensional Conformal Radiation Therapy
- +3 more
-
Birmingham, Alabama
- +179 more
Oct 5, 2021
Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))
Completed
- Brain Tumor
- +4 more
- Zotiraciclib (TG02)
- Temozolomide (TMZ)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 3, 2021
Recurrent Glioblastoma, Recurrent Adult Brain Tumor, Gliosarcoma Trial in United States (HSPPC-96, bevacizumab)
Active, not recruiting
- Recurrent Glioblastoma
- +2 more
- HSPPC-96
- bevacizumab
-
Anchorage, Alaska
- +416 more
Aug 16, 2021
Gliosarcoma, Recurrent Glioblastoma, Astrocytoma of Brain Trial in Palo Alto (Laboratory Biomarker Analysis, Pharmacological
Completed
- Gliosarcoma
- +3 more
- Laboratory Biomarker Analysis
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Aug 9, 2021
Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (Valproic acid, Bevacizumab, Radiation
Completed
- Glial Cell Tumors
- +7 more
- Valproic acid
- +2 more
-
Oklahoma City, Oklahoma
- +5 more
Jun 30, 2021
Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)
Completed
- Brain Cancer
- +10 more
- DNX-2401
- pembrolizumab
-
Little Rock, Arkansas
- +14 more
Jul 13, 2021